House Judiciary IP Counsel Teases Upcoming PERA Companion Bill at IPWatchdog LIVE, Addressing Stalled Patent Reforms

By Eileen McDermott (Enriched & Expanded Report)
Published in context from IPWatchdog LIVE

Executive Summary: Main Facts

During Day Two of the annual IPWatchdog LIVE conference, intellectual property leaders, legal practitioners, and policy experts gathered to dissect the sluggish pace of U.S. patent reform. A central highlight of the proceedings was an update from J. John Lee, Chief Counsel for Intellectual Property for the U.S. House of Representatives Committee on the Judiciary.

Addressing widespread skepticism regarding the future of the Patent Eligibility Restoration Act (PERA)—championed in the Senate by Senators Thom Tillis (R-NC) and Chris Coons (D-CT)—Lee revealed that a companion House version of the legislation is anticipated in the near future.

Lee, who serves as the principal advisor on intellectual property issues and helms the House Subcommittee on Courts, Intellectual Property, and the Internet, participated in a high-profile panel titled "Politics, Policy and Legislation at the Intersection of Intellectual Property." He was joined by David Jones of the High-Tech Inventors Alliance (HTIA), Joe Matal of Haynes Boone, LLP (and former Acting Director and Acting Solicitor of the U.S. Patent and Trademark Office), and Eli Mazour of Harrity & Harrity.

While the announcement of an impending House bill offers a glimmer of hope for patent owners seeking to eliminate decades of judicial exceptions to patent eligibility, the panel underscored a sobering reality: deep ideological fractures, intense stakeholder polarization, and a general lack of political consensus threaten to delay or dilute major legislative overhauls, including both PERA and the Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act.

Chronology of Events & Legislative Background

The Journey to PERA and PREVAIL

To understand the gravity of the statements made at IPWatchdog LIVE, it is necessary to examine the timeline of recent legislative efforts aimed at repairing the U.S. patent system:

• The Judicial Exception Crisis (2012–2023): For over a decade, decisions by the U.S. Supreme Court (such as Alice Corp. v. CLS Bank and Mayo Collaborative Services v. Prometheus Laboratories) and the resulting jurisprudence at the U.S. Court of Appeals for the Federal Circuit created widespread uncertainty. Critics argue these rulings unfairly invalidated patents across vital industries, particularly life sciences, diagnostics, software, and artificial intelligence.
• Introduction of PERA (Mid-2023): Senators Tillis and Coons introduced the Patent Eligibility Restoration Act, aiming to completely eliminate judicially created exceptions to patent eligibility and restore statutory clarity.
• Introduction of the PREVAIL Act (Mid-2023): Aimed at reforming Patent Trial and Appeal Board (PTAB) practices, the PREVAIL Act was introduced to curb perceived abuses of inter partes review (IPR) proceedings that many independent inventors and small businesses argue disproportionately harm valid patents.
• IPWatchdog LIVE Panel (September 2023): During the second day of the conference, panel discussions directly addressed the stalled momentum of these bills, culminating in John Lee’s announcement regarding the impending introduction of a House-side PERA bill.

Panel Dynamics and Official Responses

The discussion at IPWatchdog LIVE captured a microcosm of the broader war taking place across the American innovation landscape. Stakeholders ranging from independent inventors to big-tech conglomerates remain fundamentally misaligned on what the future of U.S. IP law should look like.

1. The House Perspective: J. John Lee on Process vs. Immediate Passage

While Joe Matal noted that the complete absence of a current House version of PERA made its near-term prospects appear slim, John Lee urged the audience to adopt a long-term strategic view.

"That doesn’t necessarily mean it will rocket to markup," Lee cautioned the attendees, framing the anticipated House bill as "just a step in a process" toward comprehensive patent reform.

Lee also touched upon the PREVAIL Act, acknowledging that while a House counterpart targeting PTAB overhaul exists, it remains in its legislative infancy. Lee stated he does not expect substantial legislative movement on PREVAIL in the immediate future due to competing priorities and ongoing stakeholder friction.

Furthermore, Lee highlighted the broader legislative docket for the House IP Subcommittee, noting that lawmakers will soon shift their attention to emerging technological and regulatory frontiers, including:

• Artificial intelligence (AI) and IP ownership/infringement.
• Congressional oversight of the U.S. Copyright Office.
• Standard Essential Patents (SEPs).
• The escalating crisis of global counterfeiting.

2. The Partisan and Cultural Divide in Washington

Reflecting on why major patent reforms routinely stall in Congress, Lee pointed to a toxic national political environment. He noted that contemporary political discourse forces lawmakers to focus on "exceptions rather than the rules."

"That’s driving divisiveness in the country, and a refusal to work together — it’s really poisonous," Lee lamented, emphasizing that technical, highly complex areas like intellectual property are increasingly caught in the crossfire of hyper-partisan gridlock.

3. Joe Matal’s Blunt Assessment of Stakeholder Positions

Joe Matal injected fierce candor into the debate regarding how the patent community views PERA. Having served as Acting Director and Acting Solicitor at the USPTO, Matal possesses deep institutional insight into administrative patent mechanics.

While acknowledging that some practitioners harbor valid reservations regarding specific statutory phrasing within PERA, Matal unleashed sharp criticism against certain advocacy groups, specifically calling out the position taken by US Inventor. Matal bluntly characterized their stance as "crazy."

Echoing sentiments previously raised by IPWatchdog founder Gene Quinn, Matal asserted:

"Gene is right. The bill is clearly beneficial, clearly pro-patent. People need to stop listening to US Inventor."

Matal’s comments underscore an intense internal schism within the pro-patent community: a rift between practitioners and organizations who view PERA as an essential corrective measure, and grassroots factions that fear unintended loopholes or compromises.

4. The Big-Tech Perspective: David Jones on Compromise

Representing the High-Tech Inventors Alliance (HTIA)—whose prominent members include tech giants like Microsoft, Amazon, Intel, and Google—David Jones offered a more pragmatic, albeit cautious, assessment.

Jones confirmed that HTIA does not currently support PERA in its exact, present form. However, he signaled a potential pathway toward compromise. Jones suggested that if stakeholders are willing to negotiate—such as exploring sui generis (unique, tailored) protections for specific categories of inventions or accepting targeted legislative concessions—a consensus could theoretically be reached.

Evaluating the broader regulatory climate, Jones described the current state of U.S. patent policy as "mixed but probably mostly positive" from the perspective of major technology implementers.

Supporting Data & Stakeholder Landscape

To contextualize the debate at IPWatchdog LIVE, it is vital to review the opposing camps influencing the congressional debate over PERA and PREVAIL:

Broader Implications for the U.S. Patent System

The revelations from the IPWatchdog LIVE panel carry profound implications for inventors, corporations, and legal practitioners navigating the U.S. innovation ecosystem.

1. The Long Road to Eligibility Reform

For more than a decade, innovators in biotech, medical diagnostics, AI, and software have operated under a cloud of legal unpredictability. While the introduction of a House companion bill for PERA will not instantly cure the legislative gridlock, it marks an essential procedural milestone. Without a bicameral push from both the Senate and the House, substantive reform of 35 U.S.C. § 101 remains a dead letter. Lee’s warning that the bill will not "rocket to markup" serves as a reality check: stakeholders must prepare for a protracted lobbying and negotiation cycle.

2. The PTAB Reform Stalemate

The stagnation of the PREVAIL Act highlights the deep entrenchment of interests surrounding the Patent Trial and Appeal Board. Large technology firms and financial institutions heavily rely on IPR proceedings to invalidate troublesome patents efficiently. Conversely, independent inventors and venture-backed startups view the PTAB as a "death squad" for patents. As long as these diametrically opposed views persist, legislative relief for administrative patent challenges will likely remain frozen.

3. The Need for Cross-Industry Compromise

As David Jones noted, movement will require compromise. If the biotech and pharmaceutical sectors—which desperately need PERA to protect patent-eligible medical diagnostics—cannot find common ground with high-tech software implementers, Congress will continue to lack the unified backing necessary to force a vote.

Conclusion

The panels at IPWatchdog LIVE underscored both the promise and the peril facing U.S. intellectual property law. J. John Lee’s confirmation that a House version of PERA is on the horizon provides a tangible beacon of hope for patent advocates who feared the legislation would languish exclusively in the Senate.

Yet, as Joe Matal, David Jones, and Eli Mazour illustrated, bridging the gap between radically different ideological factions will require immense political will, a departure from toxic partisan rhetoric, and a willingness among stakeholders to accept pragmatic legislative compromises.

As the House Judiciary IP Subcommittee expands its focus into artificial intelligence, copyright oversight, and international counterfeiting, the fate of America’s innovation economy hangs in the balance. Stakeholders across all sectors must remain actively engaged as the legislative text develops.

Disclaimer: The reporting and commentary published by IPWatchdog and summarized here do not constitute legal advice nor create an attorney-client relationship. Opinions expressed by panelists and authors reflect their personal views at the time of publication.